Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-08-03

Clinical Trial Update: Fecal Microbiota Transplantation for Irritable Bowel Syndrome [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/Phase 3 clinical trial update on fecal microbiota transplantation for irritable bowel syndrome ongoing recruitment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fecal microbiota transplantation (fecal microbiota transplantation)

Snippet

Sponsor: Guangzhou First People's Hospital | Conditions: Irritable Bowel Syndrome, Fecal Microbiota Transplantation | Phase 2, Phase 3 | Status: RECRUITING